Market Cap 4.47M
Revenue (ttm) 1.41M
Net Income (ttm) -7.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -522.70%
Debt to Equity Ratio 0.00
Volume 16,000
Avg Vol 133,386
Day's Range N/A - N/A
Shares Out 2.66M
Stochastic %K 82%
Beta 2.65
Analysts Sell
Price Target $3.70

Company Profile

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumoni...

Industry: Biotechnology
Sector: Healthcare
Phone: 202 327 5422
Address:
1025 Connecticut Avenue NW, Suite 1000, Washington, United States
topstockalerts
topstockalerts Jun. 17 at 6:15 PM
$SXTP that was a sharp rejection of lower prices.
0 · Reply
Goatcheese
Goatcheese Jun. 17 at 5:41 PM
$SXTP what’s the news
1 · Reply
Fringe
Fringe Jun. 17 at 4:21 PM
$SXTP nice scalp Run already over That was fast.
0 · Reply
uptrend2025
uptrend2025 Jun. 17 at 4:20 PM
$SXTP Wow nice move!
0 · Reply
Technicalcharter
Technicalcharter Jun. 17 at 4:00 PM
$SXTP remember this when you see this moving
1 · Reply
DipBuyInvester
DipBuyInvester Jun. 17 at 3:49 PM
$SXTP Told you!! Patience is the key. $HITI is next.
2 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 15 at 10:55 PM
$SXTP CEO purchased 7,350 shares at $1.38 for a total of $10,131. DOW GEOFFREY S now owns 24,131 shares. https://ceo-buys.com
0 · Reply
Technicalcharter
Technicalcharter Jun. 15 at 8:34 PM
$SXTP double bottom is tested and now 1.87 then 2.39 incoming
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 15 at 4:06 PM
$SXTP Will turn into 90 degrees from 60 degrees. Stay tuned.
1 · Reply
DipBuyInvester
DipBuyInvester Jun. 15 at 12:33 PM
$SXTP Moving up as expected. Load the boat.
0 · Reply
Latest News on SXTP
60 Degrees Pharmaceuticals Proxy statement: Proxy filing

Jun 8, 2026, 8:00 AM EDT - 16 days ago

60 Degrees Pharmaceuticals Proxy statement: Proxy filing


60 Degrees Pharmaceuticals Announces First Quarter 2026 Results

May 15, 2026, 8:42 AM EDT - 5 weeks ago

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results


60 Degrees Pharmaceuticals Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 5 weeks ago

60 Degrees Pharmaceuticals Quarterly report: Q1 2026


60 Degrees Pharmaceuticals Earnings release: Q1 2026

May 15, 2026, 7:00 AM EDT - 5 weeks ago

60 Degrees Pharmaceuticals Earnings release: Q1 2026


60 Degrees Pharmaceuticals Announces 2025 Annual Results

Mar 31, 2026, 7:01 AM EDT - 3 months ago

60 Degrees Pharmaceuticals Announces 2025 Annual Results


60 Degrees Pharmaceuticals Annual report: Q4 2025

Mar 30, 2026, 7:00 AM EDT - 3 months ago

60 Degrees Pharmaceuticals Annual report: Q4 2025


60 Degrees submits NDIN to FDA for Australian Chestnut Extract

2026-03-18T12:12:35.000Z - 3 months ago

60 Degrees submits NDIN to FDA for Australian Chestnut Extract


60 Degrees expands access to Arakoda with GoodRx partnership

2026-02-02T13:21:06.000Z - 5 months ago

60 Degrees expands access to Arakoda with GoodRx partnership

GDRX


60 Degrees Pharmaceuticals Inc trading halted, news pending

2026-01-17T00:50:18.000Z - 5 months ago

60 Degrees Pharmaceuticals Inc trading halted, news pending


60 Degrees Pharmaceuticals Earnings release: Q3 2025

Nov 13, 2025, 4:00 PM EST - 7 months ago

60 Degrees Pharmaceuticals Earnings release: Q3 2025


60 Degrees Pharmaceuticals Quarterly report: Q3 2025

Nov 13, 2025, 4:00 PM EST - 7 months ago

60 Degrees Pharmaceuticals Quarterly report: Q3 2025


60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results

Nov 13, 2025, 1:51 PM EST - 7 months ago

60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results


60 Degrees Pharmaceuticals Transcript: Investor Update

Oct 22, 2025, 4:15 PM EDT - 8 months ago

60 Degrees Pharmaceuticals Transcript: Investor Update


60 Degrees Pharmaceuticals Proxy statement: Proxy Filing

Sep 2, 2025, 8:00 AM EDT - 10 months ago

60 Degrees Pharmaceuticals Proxy statement: Proxy Filing


60 Degrees Pharmaceuticals Proxy statement: Proxy Filing

Aug 27, 2025, 8:00 AM EDT - 10 months ago

60 Degrees Pharmaceuticals Proxy statement: Proxy Filing


60 Degrees Pharmaceuticals Proxy statement: Proxy Filing

Aug 15, 2025, 8:00 AM EDT - 11 months ago

60 Degrees Pharmaceuticals Proxy statement: Proxy Filing


60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results

Aug 13, 2025, 4:14 PM EDT - 11 months ago

60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results


60 Degrees Pharmaceuticals Earnings release: Q2 2025

Aug 13, 2025, 7:00 AM EDT - 11 months ago

60 Degrees Pharmaceuticals Earnings release: Q2 2025


60 Degrees Pharmaceuticals Quarterly report: Q2 2025

Aug 13, 2025, 7:00 AM EDT - 11 months ago

60 Degrees Pharmaceuticals Quarterly report: Q2 2025


60 Degrees Pharmaceuticals Quarterly report: Q1 2025

May 15, 2025, 12:30 PM EDT - 1 year ago

60 Degrees Pharmaceuticals Quarterly report: Q1 2025


60 Degrees Pharmaceuticals Earnings release: Q4 2024

Mar 27, 2025, 2:30 PM EDT - 1 year ago

60 Degrees Pharmaceuticals Earnings release: Q4 2024


60 Degrees Pharmaceuticals Annual report: Q4 2024

Mar 27, 2025, 2:30 PM EDT - 1 year ago

60 Degrees Pharmaceuticals Annual report: Q4 2024


60 Degrees Pharmaceuticals Slides: Q4 2024

Mar 27, 2025, 2:30 PM EDT - 1 year ago

60 Degrees Pharmaceuticals Slides: Q4 2024


60 Degrees Pharmaceuticals Quarterly report: Q3 2024

Nov 13, 2024, 12:30 PM EST - 1 year ago

60 Degrees Pharmaceuticals Quarterly report: Q3 2024


60 Degrees Pharmaceuticals Proxy statement: Proxy Filing

Oct 15, 2024, 8:00 AM EDT - 1 year ago

60 Degrees Pharmaceuticals Proxy statement: Proxy Filing


60 Degrees Pharmaceuticals Proxy statement: Proxy Filing

Oct 2, 2024, 8:00 AM EDT - 1 year ago

60 Degrees Pharmaceuticals Proxy statement: Proxy Filing


60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results

Aug 14, 2024, 11:01 AM EDT - 2 years ago

60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results


60 Degrees Pharmaceuticals Quarterly report: Q2 2024

Aug 14, 2024, 7:00 AM EDT - 2 years ago

60 Degrees Pharmaceuticals Quarterly report: Q2 2024


60 Degrees Pharmaceuticals Earnings release: Q2 2024

Aug 14, 2024, 7:00 AM EDT - 2 years ago

60 Degrees Pharmaceuticals Earnings release: Q2 2024


topstockalerts
topstockalerts Jun. 17 at 6:15 PM
$SXTP that was a sharp rejection of lower prices.
0 · Reply
Goatcheese
Goatcheese Jun. 17 at 5:41 PM
$SXTP what’s the news
1 · Reply
Fringe
Fringe Jun. 17 at 4:21 PM
$SXTP nice scalp Run already over That was fast.
0 · Reply
uptrend2025
uptrend2025 Jun. 17 at 4:20 PM
$SXTP Wow nice move!
0 · Reply
Technicalcharter
Technicalcharter Jun. 17 at 4:00 PM
$SXTP remember this when you see this moving
1 · Reply
DipBuyInvester
DipBuyInvester Jun. 17 at 3:49 PM
$SXTP Told you!! Patience is the key. $HITI is next.
2 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 15 at 10:55 PM
$SXTP CEO purchased 7,350 shares at $1.38 for a total of $10,131. DOW GEOFFREY S now owns 24,131 shares. https://ceo-buys.com
0 · Reply
Technicalcharter
Technicalcharter Jun. 15 at 8:34 PM
$SXTP double bottom is tested and now 1.87 then 2.39 incoming
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 15 at 4:06 PM
$SXTP Will turn into 90 degrees from 60 degrees. Stay tuned.
1 · Reply
DipBuyInvester
DipBuyInvester Jun. 15 at 12:33 PM
$SXTP Moving up as expected. Load the boat.
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 15 at 8:24 AM
$SXTP 60 degrees turning into 90 degrees. Load the boat.
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 12 at 10:14 PM
$SXTP Hold for gold. Patience is the key!!Anytime 2X potential.
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 12 at 11:09 AM
$SXTP will send it to next level.
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 12 at 10:44 AM
$SXTP 👀👀👀🔥🔥🔥💪💪💪🚀🚀👀👀
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 11 at 9:15 PM
$SXTP Load with confidence and patience!!
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 11 at 8:30 PM
$SXTP This is the dip!! Get on the boat!!
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 11 at 8:16 PM
$SXTP 👀👀👀🔥🔥🔥🔥🚀🚀🚀💪💪💪
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 11 at 7:59 PM
$SXTP Load quietly before the crowd. Huge news today .
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 11 at 6:55 PM
$SXTP 👀👀👀🔥🔥🔥🚀🚀🚀👀💪💪💪
0 · Reply
BioTuesdays
BioTuesdays Jun. 11 at 4:47 PM
$SXTP has announced that it has executed a patent licensing agreement with Florida State University to commence large-scale production techniques to extract and purify castanospermine from the seeds of the Australian Chestnut, the Moreton Bay Chestnut, and the Black Bean Tree, for non-prescription uses. https://biotuesdays.com/2026/06/11/60-degrees-signs-licensing-agreement-with-florida-state-for-botanical-supplement/
1 · Reply
DipBuyInvester
DipBuyInvester Jun. 11 at 2:28 PM
$SXTP 👀👀💪💪🔥🔥
0 · Reply
DipBuyInvester
DipBuyInvester Jun. 11 at 1:10 PM
$SXTP 👀👀🔥🔥🚀🚀👀👀💪💪👀👀👀
1 · Reply